Occult primary, version 3.2014; Featured updates to the NCCN guidelines
暂无分享,去创建一个
D. Ettinger | A. Rashid | D. Gierada | Deborah A. Freedman-Cass | M. Stevenson | L. Saltz | L. Shulman | R. Lenzi | R. Schwab | G. Varadhachary | J. Cates | J. Smerage | D. Bowles | M. Agulnik | M. Cristea | K. Eaton | P. Fidias | C. Handorf | R. Iyer | J. Phay | J. Zager | W. Zhen | Mary Anne Bergman | E. Dotan | W. Zhen | K. Godby | G. Gilcrease | Richard B. Schwab | Lawrence N. Shulman
[1] M. Halks-Miller,et al. A Multicenter Study Directly Comparing the Diagnostic Accuracy of Gene Expression Profiling and Immunohistochemistry for Primary Site Identification in Metastatic Tumors , 2013, The American journal of surgical pathology.
[2] Michael Thomas,et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. , 2013, The New England journal of medicine.
[3] J. Hainsworth,et al. Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology. , 2013, Journal of the National Cancer Institute.
[4] M. Erlander,et al. Blinded comparator study of immunohistochemical analysis versus a 92-gene cancer classifier in the diagnosis of the primary site in metastatic tumors. , 2013, The Journal of molecular diagnostics : JMD.
[5] J. Hainsworth,et al. Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] N. Pavlidis,et al. Cancer of unknown primary site , 2012, The Lancet.
[7] M. Mathieu,et al. Identifying the Primary Site Using Gene Expression Profiling in Patients with Carcinoma of an Unknown Primary (CUP): A Feasibility Study from the GEFCAPI , 2012, Oncology Research and Treatment.
[8] C. Handorf. Gene expression analysis and immunohistochemistry in evaluation of cancer of unknown primary: time for a patient-centered approach. , 2011, Journal of the National Comprehensive Cancer Network : JNCCN.
[9] A. Bottomley,et al. Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Jeffrey W. Clark,et al. Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with ALK-positive non-small cell lung cancer (NSCLC). , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Hainsworth,et al. Carcinoma of unknown primary site (CUP): Outcomes in patients with a colorectal molecular profile treated with site-specific chemotherapy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] R. Aharonov,et al. Prospective Gene Signature Study Using microRNA to Identify the Tissue of Origin in Patients with Carcinoma of Unknown Primary , 2011, Clinical Cancer Research.
[13] R. Aharonov,et al. A second-generation microRNA-based assay for diagnosing tumor tissue origin. , 2012, The oncologist.
[14] Denise,et al. Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction. , 2010, The oncologist.
[15] W. E. Jordan,et al. Cancer of unknown primary site. , 2010, Seminars in oncology.
[16] R. Aharonov,et al. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin , 2010, Modern Pathology.
[17] F. Monzon,et al. Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin. , 2010, Archives of pathology & laboratory medicine.
[18] F. Monzon,et al. Diagnosis of uncertain primary tumors with the Pathwork® tissue-of-origin test , 2010, Expert review of molecular diagnostics.
[19] D. Dabbs. Comprar Diagnostic Immunohistochemistry, 3rd Edition | David J. Dabbs | 9781416057666 | Saunders , 2010 .
[20] A. Glas,et al. Implementation of a novel microarray‐based diagnostic test for cancer of unknown primary , 2009, International journal of cancer.
[21] F. Monzon,et al. Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] K. Oien,et al. Pathologic evaluation of unknown primary cancer. , 2009, Seminars in oncology.
[23] M. Erlander,et al. Molecular classification of unknown primary cancer. , 2009, Seminars in oncology.
[24] G. Varadhachary,et al. Overview of patient management and future directions in unknown primary carcinoma. , 2009, Seminars in oncology.
[25] Kenneth R Hess,et al. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] Arno Floore,et al. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] R. Aharonov,et al. MicroRNAs accurately identify cancer tissue origin , 2008, Nature Biotechnology.
[28] M. Wick. Immunohistochemical approaches to the diagnosis of undifferentiated malignant tumors. , 2008, Annals of diagnostic pathology.
[29] J. Pollack,et al. Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers. , 2008, The Journal of molecular diagnostics : JMD.
[30] R. Salunga,et al. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. , 2009, Archives of pathology & laboratory medicine.
[31] David C. Atkins,et al. A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin. , 2006, The Journal of molecular diagnostics : JMD.
[32] J. Hainsworth,et al. Diagnostic and therapeutic management of cancer of an unknown primary. , 2003, European journal of cancer.
[33] N. Pavlidis. Cancer of unknown primary: biological and clinical characteristics. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[34] J. Hainsworth,et al. Tumors of unknown origin , 1992, CA: a cancer journal for clinicians.